Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 427 entries
View as:

A Study to Assess Disease Burden, in Terms of Health-related Quality of Life and Direct Healthcare Costs, in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Autologous Stem Cell Transplant (ASCT) in Spain

Phase: N/A Priority: Normal
NCT ID: NCT02946333 Org: User:
Start: 12/25/16 End: 10/31/22 Due: 10/31/23

Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impaired Renal Function (POM Renal)

Phase: N/A Priority: Normal
NCT ID: NCT01575925 Org: User:
Start: 06/01/12 End: 08/07/18 Due: 08/07/19

Radiolabeled Study of AG-221 in Healthy Male Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT02443168 Org: User:
Start: 05/14/15 End: 07/21/15 Due: 07/21/16

Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) in Participants With Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS).

Phase: N/A Priority: Normal
NCT ID: NCT01835587 Org: User:
Start: 10/25/13 End: 05/26/17 Due: 05/26/18

Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00540514 Org: User:
Start: 11/01/07 End: 02/01/13 Due: 02/01/14

Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02323906 Org: User:
Start: 01/16/15 End: 12/21/16 Due: 12/21/17

A Study to Evaluate the Relative Bioavailability of a Pediatric Granule Formulation of Ozanimod in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04528290 Org: User:
Start: 10/07/20 End: 06/01/21 Due: 06/01/22

Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00761722 Org: User:
Start: 08/12/08 End: 04/07/16 Due: 04/07/17

Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01324310 Org: User:
Start: 04/01/11 End: 01/01/12 Due: 01/01/13

ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02551185 Org: User:
Start: 12/22/15 End: 10/04/19 Due: 10/04/20

Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single Ascending Doses of CC-92480 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03803644 Org: User:
Start: 12/21/18 End: 05/28/19 Due: 05/28/20

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Phase: N/A Priority: Normal
NCT ID: NCT03435796 Org: User:
Start: 07/19/18 End: 11/30/36 Due: 11/30/37

A Study to Assess the Pharmacokinetics of CC-90001 in Subjects With Mild, Moderate, and Severe Hepatic Impairment Compared With Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03742882 Org: User:
Start: 12/06/18 End: 06/10/19 Due: 06/10/20

CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT04047303 Org: User:
Start: 01/02/20 End: 06/03/24 Due: 06/03/25

A Single Dose Oral Excretion Balance Study of [14C]-RPC1063 in Healthy Male Adults

Phase: N/A Priority: Normal
NCT ID: NCT02994381 Org: User:
Start: 10/31/16 End: 11/30/16 Due: 11/30/17

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06808984 Org: User:
Start: 06/09/25 End: 09/08/27 Due: 09/08/28

Study of bb2121 in Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02658929 Org: User:
Start: 12/22/15 End: 09/22/22 Due: 09/22/23

A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT04887857 Org: User:
Start: 12/01/21 End: 01/08/24 Due: 01/08/25

Metabolism and Excretion of [14C]CC-90001 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04655898 Org: User:
Start: 12/16/20 End: 03/11/21 Due: 03/11/22

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00963105 Org: User:
Start: 10/19/09 End: 09/05/17 Due: 09/05/18

Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02502188 Org: User:
Start: 07/17/15 End: 11/02/15 Due: 11/02/16

Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicular Lymphoma and Marginal Zone Lymphoma)

Phase: N/A Priority: Normal
NCT ID: NCT01938001 Org: User:
Start: 11/21/13 End: 01/26/22 Due: 01/26/23

A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) in Taiwan

Phase: N/A Priority: Normal
NCT ID: NCT01752075 Org: User:
Start: 01/01/11 End: 07/19/13 Due: 07/19/14

A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity

Phase: N/A Priority: Normal
NCT ID: NCT06782490 Org: User:
Start: 06/05/25 End: 01/27/27 Due: 01/27/28

A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT04064060 Org: User:
Start: 08/12/19 End: 05/12/28 Due: 05/12/29